Nextgen Cash Flow Conversion Efficiency

Latest as of June 2025: 0.111x

Nextgen cash flow conversion efficiency. Based on the latest financial reports, Nextgen (NXGN) has a cash flow conversion efficiency ratio of 0.111x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA-1.08 Million ≈ $-2.90K USD) by net assets (ILA-9.72 Million ≈ $-26.05K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Nextgen (2013–2024)

Cash flow conversion efficiency of Nextgen from 2013 to 2024. This chart illustrates how Nextgen's cash flow conversion efficiency has evolved over time, based on yearly financial data. View latest Nextgen stock price today for real-time trading data and today's change.

Nextgen Cash Flow Conversion Ratio Explained

Nextgen cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Nextgen Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Nextgen ranked by their cash flow conversion efficiency. Also see Nextgen (NXGN) total market value for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
MUZHU MINING LTD
F:Y33
N/A
Vault Strategic Mining Corp.
V:KNOX
-1.008x
Astron Paper & Board Mill Limited
NSE:ASTRON
0.079x
Foxtons Group Plc
LSE:FOXT
0.054x
Gabather AB (publ)
ST:GABA
-0.117x
Vanquis Banking Group PLC
LSE:VANQ
0.406x
Quartix Holdings Plc
LSE:QTX
0.121x
Link Bilgisayar Sistemleri Yazilimi ve Donanimi Sanayi ve Ticaret AS
IS:LINK
0.021x

Annual Cash Flow Conversion Efficiency for Nextgen (2013–2024)

The table below shows the annual cash flow conversion efficiency of Nextgen from 2013 to 2024. Review NXGN FCF to total liabilities ratio to assess the company's free cash flow relative to its total liabilities.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 ILA-2.46 Million
≈ $-6.61K
ILA-2.06 Million
≈ $-5.53K
0.837x -81.41%
2023-12-31 ILA-979.00K
≈ $-2.62K
ILA-4.41 Million
≈ $-11.81K
4.499x +2102.13%
2022-12-31 ILA12.25 Million
≈ $32.84K
ILA-2.75 Million
≈ $-7.38K
-0.225x -75.07%
2021-12-31 ILA20.71 Million
≈ $55.51K
ILA-2.66 Million
≈ $-7.13K
-0.128x +42.64%
2020-12-31 ILA6.87 Million
≈ $18.41K
ILA-1.54 Million
≈ $-4.12K
-0.224x +77.11%
2019-12-31 ILA1.17 Million
≈ $3.14K
ILA-1.15 Million
≈ $-3.07K
-0.978x -88.16%
2018-12-31 ILA2.39 Million
≈ $6.40K
ILA-1.24 Million
≈ $-3.33K
-0.520x -14.45%
2017-12-31 ILA3.66 Million
≈ $9.81K
ILA-1.66 Million
≈ $-4.45K
-0.454x -54.05%
2016-12-31 ILA5.13 Million
≈ $13.76K
ILA-1.51 Million
≈ $-4.06K
-0.295x +87.25%
2015-12-31 ILA1.74 Million
≈ $4.65K
ILA-4.01 Million
≈ $-10.76K
-2.312x -162.46%
2014-12-31 ILA-884.00K
≈ $-2.37K
ILA-3.27 Million
≈ $-8.77K
3.702x +205.08%
2013-12-31 ILA342.00K
≈ $916.89
ILA-1.21 Million
≈ $-3.23K
-3.523x --

About Nextgen

TA:NXGN Israel Medical Instruments & Supplies
Market Cap
$1.32 Million
ILA490.55 Million ILA
Market Cap Rank
#30467 Global
#445 in Israel
Share Price
ILA45.00
Change (1 day)
+17.19%
52-Week Range
ILA37.60 - ILA68.40
All Time High
ILA25020.00
About

Nextgen Biomed Ltd develops topical treatment for psoriasis. The company was formerly known as Sela Group.Com Ltd. and changed its name to Nextgen Biomed Ltd in February 2010. Nextgen Biomed Ltd was incorporated in 1990 and is based in Tel Aviv, Israel.